Hib (Haemophilus influenzae type b) conjugate vaccine uses polyribosylribitol phosphate (PRP) polysaccharide conjugated to a carrier protein. Why is conjugation to a carrier protein essential for efficacy in infants?

• A Plain polysaccharide antigens stimulate T-dependent (thymus-dependent) immune responses; conjugation to protein converts them to T-independent responses generating only IgM
• B Carrier protein provides adjuvant-like activity by directly stimulating innate immune cells via TLR-4, bypassing adaptive immunity requirements
• C Conjugation prevents polysaccharide degradation in the cold chain, extending shelf-life rather than changing immunogenicity
• D Plain polysaccharide antigens are T-independent (type 2) antigens that cannot generate memory B-cells or class-switching in infants under 2 years; conjugation to a protein carrier converts the response to T-dependent, generating IgG memory, boostability, and efficacy in infants ✓

Explanation

Pure polysaccharide antigens (capsular polysaccharides) are T-independent type 2 (TI-2) antigens: they activate B-cells directly by cross-linking multiple BCRs but cannot present to T-helper cells, resulting in no memory B-cells, predominantly IgM response with poor class switching, and no response in infants under 2 years (immature marginal zone B-cells). Conjugation to a protein carrier (e.g., tetanus toxoid, diphtheria CRM197) creates a T-dependent antigen: the protein portion is processed and presented on MHC II to T-helper cells, enabling germinal centre reactions, isotype switching to IgG, affinity maturation, and long-lived memory B-cells — providing protective immunity with boostability from infancy.

Reference: Ananthanarayan & Paniker's Textbook of Microbiology, 11th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.